Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Results 1-2 of 2 for drugs segment:7702430

Written Answers — Department of Health: Medicinal Products (14 Jul 2020)

Jennifer Murnane O'Connor: 1136. To ask the Minister for Health if approval will be given to the immunotherapy drug osimertinib; if a timeline can be provided for its availability for lung cancer patients; and if not, the reason. [15318/20]

Written Answers — Department of Health: Medicinal Products (14 Jul 2020)

Stephen Donnelly: The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. In line with the 2013 Act and the national framework agreed with industry, a company must submit an application to the HSE to have a new medicine added to the reimbursement list....

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person